Text:+1 (252) 283 1187 / WhatsApp: +49163 0405954

Buy Pain killer Pills Online With Express ShippingShopADD/ADHDQuillivant XR (Methylphenidate HCl) (Copy)

Quillivant XR (Methylphenidate HCl) (Copy)

$180.00

Add to wishlist Add to compareAsk about product

Description

Quillivant XR (Methylphenidate Hydrochloride) is an extended-release oral suspension used to treat Attention Deficit Hyperactivity Disorder (ADHD) in patients aged six years and older. As a central nervous system (CNS) stimulant, it increases dopamine and norepinephrine activity in the brain, helping improve focus, attention, and impulse control throughout the day.

Uses of Quillivant XR

Quillivant XR is primarily prescribed for managing ADHD symptoms, including inattention, hyperactivity, and impulsivity. Its liquid form makes it especially useful for children or adults who have difficulty swallowing pills, offering a convenient once-daily dosage.

Dosage Information

The recommended starting dose of Quillivant XR is 20 mg once daily in the morning, before school or work. Doses may be adjusted in 10–20 mg increments weekly as needed, under medical supervision. The suspension must be shaken vigorously for at least 10 seconds before each use to ensure accurate dosing. Avoid taking Quillivant XR in the afternoon or evening, as it may interfere with sleep.

Possible Side Effects

Common side effects include loss of appetite, insomnia, dry mouth, stomach pain, and increased heart rate. Serious reactions such as chest pain, mood swings, or allergic reactions may occur and require immediate medical attention.

Important Safety Information

Quillivant XR is a Schedule II controlled substance and can be habit-forming. It should be used only under a doctor’s supervision. Patients with heart conditions, anxiety, or a history of substance misuse should discuss risks with their healthcare provider before starting treatment.

Reviews

There are no reviews yet.

Be the first to review “Quillivant XR (Methylphenidate HCl) (Copy)”

Your email address will not be published. Required fields are marked *

error: Content is protected !!